Functional outcome measures for NF1-associated optic pathway glioma clinical trials.

  title={Functional outcome measures for NF1-associated optic pathway glioma clinical trials.},
  author={Michael J Fisher and Robert A. Avery and Jeffrey B. Allen and Simone L Ardern-Holmes and Larissa T. Bilaniuk and Rosalie E. Ferner and David H Gutmann and Robert H. Listernick and Staci Martin and Nicole N J Ullrich and Grant T. Liu},
  volume={81 21 Suppl 1},
OBJECTIVE The goal of the Response Evaluation in Neurofibromatosis and Schwannomatosis Visual Outcomes Committee is to define the best functional outcome measures for future neurofibromatosis type 1 (NF1)-associated optic pathway glioma (OPG) clinical trials. METHODS The committee considered the components of vision, other ophthalmologic parameters affected by OPG, potential biomarkers of visual function, and quality of life measures to arrive at consensus-based, evidence-driven… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
17 Citations
63 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 17 extracted citations


Publications referenced by this paper.
Showing 1-10 of 63 references

Abstracts from the 65th annual meeting of the American Academy of Neurology: proptosis in optic pathway gliomas associated with neurofibromatosis: response to chemotherapy

  • AY Nguyen-Phuc, D Khrichenko, T Feygin, MJ Fisher, GT. Liu
  • Neurology 2013 (http://www.abstracts2view. com…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…